Search results
5 FDA decisions to watch in the third quarter
BioPharma Dive· 15 hours agoMultibillion-dollar buyouts from Bristol Myers Squibb and Gilead could yield new drugs for brain and liver diseases, while a new cell therapy may reach...
AI and stable funding environments are catalysts for biotech assets
Pharmaceutical Technology· 6 days agoAs revenue growth is what drives biopharma share prices, what these big companies need are...
UK Election 2024: Hour-by-hour guide to how the results come in
CNBC Awaaz· 12 hours agoThe UK votes Thursday to decide whether Labour Party leader Keir Starmer can end 14 years of...
UK: Conservatives face period of irrelevance as unhappy Britons prepare to go to the polls
The Telegraph· 2 days agoThe Conservatives have dominated British politics for 14 years, holding onto power through crisis...